Skip to content

Non-Interventional, Multicenter Bicontact® E PMCF Study

Non-Interventional, Multicenter Bicontact® E PMCF Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03442855
Enrollment
73
Registered
2018-02-22
Start date
2017-02-01
Completion date
2019-05-31
Last updated
2019-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Degenerative Osteoarthritis, Femoral Head Necrosis, Femoral Neck Fractures, Rheumatoid Arthritis

Keywords

Arthroplasty, Replacement, Hip

Brief summary

Prospective observational (non-interventional) cohort study, multi-centric in 5 study Centers in Japan to collect short term clinical and radiological results of the cementless Bicontact® E stem in a standard patient population used in routine clinical practice

Interventions

None listed

Sponsors

Aesculap AG
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Indication for Bicontact E prosthesis THA * Patients ≥ 18 years * Patient not pregnant * Written informed consent

Exclusion criteria

\- Patients receiving a bipolar implantation

Design outcomes

Primary

MeasureTime frameDescription
Clinical Results1 yearHip Score of the Japanese Orthopaedic Association (JOA): three categories-movement, mental, and pain-each comprising 7 items, for a total of 21 items to be used as evaluation criteria for hip-joint function

Secondary

MeasureTime frameDescription
Thigh Pain1 yearPain as measured with the Visual Analog Scale (VAS): Visual analog scale \[VAS\] is a measure of pain intensity. It is a continuous scale comprised of a horizontal analog scale of 100 mm length. It is anchored by two verbal descriptors, one for each symptom extreme \[no pain - worst imaginable pain\].
X-Ray evaluation1 yearRadiological results (osteointegration, migration)
(Serious) Adverse Events1 yearComplications: Adverse Events (AE) / Serious Adverse Events (SAE)

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026